Citations (91)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sophie R Van Tomme & Wim E Hennink. (2007) Biodegradable dextran hydrogels for protein delivery applications. Expert Review of Medical Devices 4:2, pages 147-164.
Read now
Read now
K. Liewendahl, O. Alfthan, T. Heiskanen & A Huunan. (1973) Effects of Dextran on Postoperative Renal Function Measured by a Single Injection Clearance Method. Scandinavian Journal of Urology and Nephrology 7:1, pages 38-42.
Read now
Read now
C. E. Mogensen. (1968) Chromatographic Evidence by Sephadex Gel Filtration of the Unrestricted Glomerular Filtration of Inulin. Scandinavian Journal of Clinical and Laboratory Investigation 22:3, pages 203-207.
Read now
Read now
C. E. Mogensen. (1968) The Glomerular Permeability Determined by Dextran Clearance Using Sephadex Gel Filtration. Scandinavian Journal of Clinical and Laboratory Investigation 21:1, pages 77-82.
Read now
Read now
J. Krôll. (1965) Studies on The Effect of low Molecular Weight Dextran Upon the Clotting Process in Vitro. Scandinavian Journal of Clinical and Laboratory Investigation 17:1, pages 51-56.
Read now
Read now
Articles from other publishers (86)
Tiantian Guo, Haiping Zhong, Xingwei Li, Jingqing Mu, Tao Liu, Na Yu, Yang Zhao, Xing-Jie Liang & Shutao Guo. (2023) Drug content on anticancer efficacy of self-assembling ketal-linked dextran-paclitaxel conjugates. Journal of Controlled Release 359, pages 175-187.
Crossref
Crossref
Joseph F. Hassler, Adelyn Crabtree, Lucy Liberman, Frank S. Bates, Benjamin J. Hackel & Timothy P. Lodge. (2022) Effect of Bottlebrush Poloxamer Architecture on Binding to Liposomes. Biomacromolecules 24:1, pages 449-461.
Crossref
Crossref
Lisa R. Volpatti, Matthew A. Bochenek, Amanda L. Facklam, Delaney M. Burns, Corina MacIsaac, Alexander Morgart, Benjamin Walters, Robert Langer & Daniel G. Anderson. (2022) Partially Oxidized Alginate as a Biodegradable Carrier for Glucose‐Responsive Insulin Delivery and Islet Cell Replacement Therapy. Advanced Healthcare Materials 12:2.
Crossref
Crossref
Yifan Cai, Jianping Qi, Yi Lu, Haisheng He & Wei Wu. (2022) The in vivo fate of polymeric micelles. Advanced Drug Delivery Reviews 188, pages 114463.
Crossref
Crossref
Ranjit De, Manoj Kumar Mahata & Kyong‐Tai Kim. (2022) Structure‐Based Varieties of Polymeric Nanocarriers and Influences of Their Physicochemical Properties on Drug Delivery Profiles. Advanced Science 9:10, pages 2105373.
Crossref
Crossref
Oscar Kolsrud, Mikael Barbu, Göran Dellgren, Kerstin Björk, Anna Corderfeldt, Anders Thoren, Anders Jeppsson & Sven‐Erik Ricksten. (2021) Dextran‐based priming solution during cardiopulmonary bypass attenuates renal tubular injury—A secondary analysis of randomized controlled trial in adult cardiac surgery patients. Acta Anaesthesiologica Scandinavica 66:1, pages 40-47.
Crossref
Crossref
Yeliz Basaran Elalmis, Ecem Tiryaki, Burcu Karakuzu Ikizler & Sevil Yucel. 2022. Micro- and Nanoengineered Gum-Based Biomaterials for Drug Delivery and Biomedical Applications. Micro- and Nanoengineered Gum-Based Biomaterials for Drug Delivery and Biomedical Applications
303
331
.
Maria Varghese, Rae S. Rokosh, Carolyn A. Haller, Stacy L. Chin, Jiaxuan Chen, Erbin Dai, Ruiqing Xiao, Elliot L. Chaikof & Mark W. Grinstaff. (2021)
Sulfated poly-amido-saccharides (sulPASs) are anticoagulants
in vitro
and
in vivo
. Chemical Science 12:38, pages 12719-12725.
Crossref
Crossref
Anitha A, Nicholas L. Fletcher, Zachary H. Houston, Kristofer J. Thurecht & Lisbeth Grøndahl. (2021) Evaluation of the in vivo fate of ultrapure alginate in a BALB/c mouse model. Carbohydrate Polymers 262, pages 117947.
Crossref
Crossref
Penghui Cheng, Wan Chen, Shenhua Li, Shasha He, Qingqing Miao & Kanyi Pu. (2020) Fluoro‐Photoacoustic Polymeric Renal Reporter for Real‐Time Dual Imaging of Acute Kidney Injury. Advanced Materials 32:17, pages 1908530.
Crossref
Crossref
Haoyuan Huang, Reinier Hernandez, Jumin Geng, Haotian Sun, Wentao Song, Feng Chen, Stephen A. Graves, Robert J. Nickles, Chong Cheng, Weibo Cai & Jonathan F. Lovell. (2016) A porphyrin-PEG polymer with rapid renal clearance. Biomaterials 76, pages 25-32.
Crossref
Crossref
D. M. Kirchmajer, R. Gorkin III & M. in het Panhuis. (2015) An overview of the suitability of hydrogel-forming polymers for extrusion-based 3D-printing. Journal of Materials Chemistry B 3:20, pages 4105-4117.
Crossref
Crossref
S. Moradi, O. Akhavan, A. Tayyebi, R. Rahighi, M. Mohammadzadeh & H. R. Saligheh Rad. (2015) Magnetite/dextran-functionalized graphene oxide nanosheets for in vivo positive contrast magnetic resonance imaging. RSC Advances 5:59, pages 47529-47537.
Crossref
Crossref
Michael J. Saxton. (2014) Wanted: Scalable Tracers for Diffusion Measurements. The Journal of Physical Chemistry B 118:45, pages 12805-12817.
Crossref
Crossref
Ikue Kitazawa, Shino Ito, Yusuke Kagawa, Miki Suehiro-Narita, Naoto Hashizume, Yuka Minamisawa, Aisuke Nii, Akio Kawakami & Shinichi Nakajima. (2014) Effects of Repeated Intravenous Administration of Dextrans,Water-soluble Macromolecules, in Rats. Journal of Toxicologic Pathology 27:3+4, pages 231-234.
Crossref
Crossref
Walter Mier, Susanne Krämer, Sabine Zitzmann, Annette Altmann, Karin Leotta, Ursula Schierbaum, Martina Schnölzer, Michael Eisenhut & Uwe Haberkorn. (2013) PEGylation enables the specific tumor accumulation of a peptide identified by phage display. Organic & Biomolecular Chemistry 11:16, pages 2706.
Crossref
Crossref
William H. Beierwaltes, Lisa M. Harrison‐Bernard, Jennifer C. Sullivan & David L. Mattson. 2011. Comprehensive Physiology. Comprehensive Physiology
165
200
.
Elisabeth Bellard, Bostjan Markelc, Sandrine Pelofy, François Le Guerroué, Gregor Sersa, Justin Teissié, Maja Cemazar & Muriel Golzio. (2012) Intravital microscopy at the single vessel level brings new insights of vascular modification mechanisms induced by electropermeabilization. Journal of Controlled Release 163:3, pages 396-403.
Crossref
Crossref
Monica Mazzarino, Ilaria Fiacco, Xavier Torre & Francesco Botrè. (2011) A rapid analytical method for the detection of plasma volume expanders and mannitol based on the urinary saccharides and polyalcohols profile. Drug Testing and Analysis 3:11-12, pages 896-905.
Crossref
Crossref
Marjo Kolmonen, Antti Leinonen, Tiia Kuuranne, Anna Pelander, Koen Deventer & Ilkka Ojanperä. (2011) Specific screening method for dextran and hydroxyethyl starch in human urine by size exclusion chromatography–in-source collision-induced dissociation–time-of-flight mass spectrometry. Analytical and Bioanalytical Chemistry 401:2, pages 563-571.
Crossref
Crossref
Aash P. Bhatt, Vishala T. Neppalli, Elizabeth A. Kelley, Annette J. Schlueter & Christie P. Thomas. (2011) Dextran Removal by Plasmapheresis in a Kidney-Pancreas Transplant Recipient With Dextran 40–Induced Osmotic Nephrosis. American Journal of Kidney Diseases 57:4, pages 621-623.
Crossref
Crossref
Michael Dickenmann, Tobias Oettl & Michael J. Mihatsch. (2008) Osmotic Nephrosis: Acute Kidney Injury With Accumulation of Proximal Tubular Lysosomes Due to Administration of Exogenous Solutes. American Journal of Kidney Diseases 51:3, pages 491-503.
Crossref
Crossref
Morad Askari, Christine Fisher, Frederick G. Weniger, Sean Bidic & W.P. Andrew Lee. (2006) Anticoagulation Therapy in Microsurgery: A Review. The Journal of Hand Surgery 31:5, pages 836-846.
Crossref
Crossref
Sophie R. Van Tomme, Bruno G. De Geest, Kevin Braeckmans, Stefaan C. De Smedt, Florence Siepmann, Juergen Siepmann, Cornelus F. van Nostrum & Wim E. Hennink. (2005) Mobility of model proteins in hydrogels composed of oppositely charged dextran microspheres studied by protein release and fluorescence recovery after photobleaching. Journal of Controlled Release 110:1, pages 67-78.
Crossref
Crossref
Darrell Brooks, Phillip Okeefe & Harry J. Buncke. (2001) Dextran-Induced Acute Renal Failure after Microvascular Muscle Transplantation. Plastic and Reconstructive Surgery 108:7, pages 2057-2060.
Crossref
Crossref
Lucia J.M. Kroft & Albert de Roos. (1999) Blood pool contrast agents for cardiovascular MR imaging. Journal of Magnetic Resonance Imaging 10:3, pages 395-403.
Crossref
Crossref
Terry S. Desser, Daniel L. Rubin, Holde H. Muller, Fan Qing, Samer Khodor, George Zanazzi, Stuart W. Young, David L. Ladd, Jennifer A. Wellons, Kenneth E. Kellar, John L. Toner & Robert A. Snow. (2005) Dynamics of tumor imaging with Gd‐DTPA—polyethylene glycol polymers: Dependence on molecular weight. Journal of Magnetic Resonance Imaging 4:3, pages 467-472.
Crossref
Crossref
Kevin T. Concannon. (2007) Colloid Oncotic Pressure and the Clinical Use of Colloidal Solutions. Journal of Veterinary Emergency and Critical Care 3:2, pages 49-62.
Crossref
Crossref
Norman G. Levinsky & Wilfred Lieberthal. 2011. Comprehensive Physiology. Comprehensive Physiology
227
247
.
Reza Mehvar & Tracy L. Shepard. (1992) Molecular-Weight-Dependent Pharmacokinetics of Fluorescein-Labeled Dextrans in Rats. Journal of Pharmaceutical Sciences 81:9, pages 908-912.
Crossref
Crossref
Michael A. Dubick, Barbara A. Ryan, James J. Summary & Charles E. Wade. (2008) Dextran metabolism following infusion of 7.5% NaCl/6% dextran‐70 to euvolemic and hemorrhaged rabbits. Drug Development Research 25:1, pages 29-38.
Crossref
Crossref
Robert C. Brasch. (1991) Rationale and applications for macromolecular Gd-based contrast agents. Magnetic Resonance in Medicine 22:2, pages 282-287.
Crossref
Crossref
Shinsuke Nomura, Tadatoshi Eimoto, Gengo Osawa, Yoshihito Yawata & Masaharu Horino. (1991) Case Report: Hypothyroidism as a Possible Cause of an Acquired Reversible Hemolytic Anemia. The American Journal of the Medical Sciences 302:1, pages 23-30.
Crossref
Crossref
L. Salemark, J.B. Wieslander, P. Dougan & B. Arnljots. (1991) Studies of the antithrombotic effects of dextran 40 following microarterial trauma. British Journal of Plastic Surgery 44:1, pages 15-22.
Crossref
Crossref
Günter SeyffartGünter Seyffart. 1991. Drug Dosage in Renal Insufficiency. Drug Dosage in Renal Insufficiency
172
217
.
J. Kienlen, J.C. Mathieu-Daudé, D. Passeron, A. Dellord, F. d'Athis & J. du Cailar. (1990) Pharmacocinétique et modifications des propriétés physiques du sang et des urines après administration d'un dextran 60 000. Annales Françaises d'Anesthésie et de Réanimation 9:6, pages 495-500.
Crossref
Crossref
Claus Larsen. (1989) Dextran prodrugs — structure and stability in relation to therapeutic activity. Advanced Drug Delivery Reviews 3:1, pages 103-154.
Crossref
Crossref
Mark Moran & Curtis Kapsner. (1987) Acute Renal Failure Associated with Elevated Plasma Oncotic Pressure. New England Journal of Medicine 317:3, pages 150-153.
Crossref
Crossref
John K. Leypoldt, Ronald P. Frigon, Karl W. Devore & Lee W. Henderson. (1987) A rapid renal clearance methodology for dextran. Kidney International 31:3, pages 855-860.
Crossref
Crossref
R.G. Melton, C.N. Wiblin, A. Baskerville, R.L. Foster & R.F. Sherwood. (1987) Covalent linkage of carboxypeptidase G2 to soluble dextrans—II. Biochemical Pharmacology 36:1, pages 113-121.
Crossref
Crossref
H. Kiesewetter, F. Jung, J. Blume, B. Bulling & R. P. Franke. (1986) Vergleichende Untersuchung von niedermolekularem Dextranoder Hydroxyäthylstärkelösungen als Volumenersatzmittel bei HämodilutionstherapieComparative investigation of low molecular dextran or hydroxyethyl starch as volume substitute solution during hemodilution. Klinische Wochenschrift 64:1, pages 29-37.
Crossref
Crossref
Marion P. Cullen, Charles Turner & George B. Haycock. (1985) Gel permeation chromatography with interference refractometry for the rapid assay of polydisperse dextrans in biological fluids. Journal of Chromatography B: Biomedical Sciences and Applications 337, pages 29-36.
Crossref
Crossref
Y Zurovsky, M Ovadia & A Shkolnik. (1985) Disappearance of dextran 70,000 from plasma of hamadryas baboons. Comparative Biochemistry and Physiology Part A: Physiology 80:3, pages 373-375.
Crossref
Crossref
H. Köhler, H. Zschiedrich, A. Linfante, F. Appel, H. Pitz & R. Clasen. (1982) Die Elimination von Hydroxyäthylstärke 200/0,5, Dextran 40 und OxypolygelatineThe elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine. Klinische Wochenschrift 60:6, pages 293-301.
Crossref
Crossref
Ingemar BERGGÅRD, Birgiua EKSTRÖM, Elwira LISOWSKA & Arne LUNDBLAD. (2005) Isolation and Characteristics of Human Urinary Sialoglycoproteins. European Journal of Biochemistry 115:1, pages 183-188.
Crossref
Crossref
Timo Waris & Timo Tervo. (1980) Barrier properties of rat subcutaneous nerves to sodium fluorescein and fluorescein-labelled dextrans of various molecular weights. Archives of Dermatological Research 267:1, pages 1-5.
Crossref
Crossref
Arthur A. Sasahara, G.V.R.K. Sharma & Alfred F. Parisi. (1979) New developments in the detection and prevention of venous thromboembolism. The American Journal of Cardiology 43:6, pages 1214-1224.
Crossref
Crossref
T. Tervo, F. Joó, A. Palkama & L. Salminen. (1979) Penetration barrier to sodium fluorescein and fluorescein-labelled dextrans of various molecular sizes in brain capillaries. Experientia 35:2, pages 252-254.
Crossref
Crossref
Jan Castenfors. (1977) RENAL FUNCTION DURING PROLONGED EXERCISE. Annals of the New York Academy of Sciences 301:1 The Marathon, pages 151-159.
Crossref
Crossref
H. K�hler. (1977) Prophylaxe und Therapie der Shuntthrombose bei terminaler NiereninsuffizienzProphylaxis and therapy of shunt thrombosis in terminal renal insufficiency. Klinische Wochenschrift 55:2, pages 49-56.
Crossref
Crossref
P. Emmrich, W. Baumann & Ursula Stechele. (1977) Studies on the kinetics and renal excretion of low and high molecular weight dextrans in preterm babies, newborns and young infants. European Journal of Pediatrics 125:3, pages 181-190.
Crossref
Crossref
L. Šprincl, J. Exner, O. Štěrba & J. Kopeček. (2004)
New types of synthetic infusion solutions. III. Elimination and retention of poly‐[
N
‐(2‐hydroxypropyl)methacrylamide] in a test organism
. Journal of Biomedical Materials Research 10:6, pages 953-963.
Crossref
Crossref
Richard C. Cabot, Robert E. Scully, James J. Galdabini, Betty U. McNeely, Julie R. Ingelfinger & Robert T. McCluskey. (1976) Case 23-1976. New England Journal of Medicine 294:23, pages 1278-1284.
Crossref
Crossref
Steve C. Raskins. (1976) Blood Volume Support. Veterinary Clinics of North America 6:2, pages 265-275.
Crossref
Crossref
H. -H. Parving, I. Noer, T. Deckert, P. -E. Evrin, S. L. Nielsen, J. Lyngs�e, C. E. Mogensen, M. R�rth, P. Aa. Svendsen, J. Trap-Jensen & N. A. Lassen. (1976) The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. Diabetologia 12:2, pages 161-166.
Crossref
Crossref
H. K�hler, T. R. Weihrauch, P. Fiegel, W. Kirch & D. H�ffler. (1975) Dosierung und Elimination von Dextran 40 bei H�modialysepatientenDosage and elimination of Dextran 40 in patients on hemodialysis. Klinische Wochenschrift 53:11, pages 523-527.
Crossref
Crossref
SHU CHIEN. 1975. The Red Blood Cell. The Red Blood Cell
1031
1133
.
V. Draxler, H. Wagner, F. Zekert, P. Sporn, C. Watzek & K. Steinbereithner. (1975) Studies on a modified dextrane-ringer's-lactate mixture in intensive care patients. European Journal of Intensive Care Medicine 1:1, pages 43-47.
Crossref
Crossref
I. S. S. Bergelin & B. W. Karlsson. (1975) Functional structure of the glomerular filtration barrier and the proximal tubuli in the developing foetal and neonatal pig kidney. Anatomy and Embryology 148:3, pages 223-234.
Crossref
Crossref
M. D. Poulik & R. A. Reisfeld. 1975. Contemporary Topics in Molecular Immunology. Contemporary Topics in Molecular Immunology
157
204
.
H. K�hler, W. Kirch, D. H�ffler & P. Koeppe. (1974) Pharmakokinetik und Dosierung von Dextran 40 in Abh�ngigkeit von der NierenfunktionPharmacocinetics and dosage of dextran 40 in relation to renal function. Klinische Wochenschrift 52:23, pages 1111-1116.
Crossref
Crossref
Ingemar S.S. Bergelin & Börje W. Karlsson. (1974) Colostrum, serum and kidney proteins in the urine of the developing neonatal pig. International Journal of Biochemistry 5:11-12, pages 885-894.
Crossref
Crossref
I. Aursnes. (2009) Blood Platelet Production and Red Cell Leakage to Lymph during Thrombocytopenia. Scandinavian Journal of Haematology 13:3, pages 184-195.
Crossref
Crossref
H. Carlsson, S. Lindvall & B. Thafvelin. (1974) Properties of a Complex of Iron and a Sorbitol-Gluconic Acid Polymer for Treatment of Piglet AnaemiaEgenskaper hos ett komplex av järn med en sorbitol-glukonsyra-polymer avsett för profylaxbehandling av smågrisanemi. Acta Veterinaria Scandinavica 15:1, pages 100-110.
Crossref
Crossref
J. F. BergmannH. Köhler, W. Kirch, D. Höffler & P. Koeppe. 1974. Achtzigster Kongress. Achtzigster Kongress
662
665
.
W. Strober, R. P. Mogielnicki & T. A. Waldmann. 1973. Ciba Foundation Symposium 9 - Protein Turnover. Ciba Foundation Symposium 9 - Protein Turnover
25
45
.
H. Lutz. (1972) 23. Parenterale Therapie mit BlutersatzmittelnParenteral therapy with blood substitute fluids. Langenbecks Archiv f�r Chirurgie 332:1, pages 245-252.
Crossref
Crossref
I. Drummond Rennie. (1971) Proteinuria. Medical Clinics of North America 55:1, pages 213-230.
Crossref
Crossref
P. P. Lambert, J. P. Gass�e, A. Verniory & P. Ficheroulle. (1971) Measurement of the glomerular filtration pressure from sieving data for macromolecules. Pfl�gers Archiv European Journal of Physiology 329:1, pages 34-58.
Crossref
Crossref
Alan M. Robson & Charles B. Manley. (1970) Pediatric renal disease. Current Problems in Pediatrics 1:2, pages 3-48.
Crossref
Crossref
Robert Mulhausen, David C. Brown & Gerald Onstad. (1969) Renal clearance of amylase during pancreatitis. Metabolism 18:8, pages 669-674.
Crossref
Crossref
L. Arisz, B. P. Hazenberg, A. Zanten & E. Mandema. (2009) RENAL EXCRETION OF LOW AND HIGH MOLECULAR WEIGHT POLYVINYLPYRROLIDONE (PVP) IN PATIENTS WITH PROTEINURIA. Acta Medica Scandinavica 186:1-6, pages 393-400.
Crossref
Crossref
P. Emmrich, B. -K. J�ngst & W. Appel. (1969) Verweildauer und renale Ausscheidung niedermolekularer Dextrane bei Neugeborenen und S�uglingenPersistence and renal excretion of low molecular weight dextran in newborns and infants. Zeitschrift f�r Kinderheilkunde 106:4, pages 298-307.
Crossref
Crossref
D. Langrehr & I. Riecken. 1969. Venendruckmessung. Venendruckmessung
48
61
.
G. Hierholzer, J. Rehn & M. Gatos. (1968) Untersuchungen zur Frage der Beeinflussung des Kohlenhydratstoffwechsels durch DextraninfusionenThe effect of dextran infusions on carbohydrate metabolism. Langenbecks Archiv f�r Klinische Chirurgie 321:4, pages 349-358.
Crossref
Crossref
W. F. HEALE, J. F. NIALL & J. C. DOYLE. (1968) The Renal Handling of Dextran 40 by Surgical Patients. Australian and New Zealand Journal of Surgery 38:2, pages 168-172.
Crossref
Crossref
D. Burrows, R. G. Shanks & C. J. Stevenson. (1968) THERAPEUTICS IV. British Journal of Dermatology 80:11, pages 767-769.
Crossref
Crossref
. (1967) References. Acta Physiologica Scandinavica 70, pages 40-44.
Crossref
Crossref
Charles M. Evarts. (1967) Low Molecular Weight Dextran. Medical Clinics of North America 51:5, pages 1285-1299.
Crossref
Crossref
Peter B. Brown. (1967) The effect of low molecular weight dextran on the micro-circulation of skin. British Journal of Plastic Surgery 20, pages 272-277.
Crossref
Crossref
W. A. Evans & D. Wong. (2008) RENAL CHANGES FOLLOWING THE ADMINISTRATION OF LOW MOLECULAR WEIGHT DEXTRAN. Australian and New Zealand Journal of Surgery 36:1, pages 69-73.
Crossref
Crossref
B Hulme & J Hardwicke. (2016) Kidney Function and Structure. Proceedings of the Royal Society of Medicine 59:6, pages 509-512.
Crossref
Crossref
C. R. RICKETTS. (1966) Isotopically Labelled Macromolecules in Biological Research : Dextran Labelled with Radioactive Iodine. Nature 210:5041, pages 1113-1115.
Crossref
Crossref
FREDRIK BERGLUND. (2008) Renal Clearances of Inulin, Polyfructosan‐S and a Polyethylene Glycol (PEG 1,000) in the Rat. Acta Physiologica Scandinavica 64:3, pages 238-244.
Crossref
Crossref
JorgeJ. Yunis, ErnestB. Hook & Mary Mayer. (1965) D.N.A. REPLICATION ANALYSIS IN IDENTIFYING THE CYTOGENETIC DEFECT IN DOWN'S SYNDROME (MONGOLISM). The Lancet 285:7383, pages 465-466.
Crossref
Crossref
J. Stewart Cameron & RichardH.R. White. (1965) SELECTIVITY OF PROTEINURIA IN CHILDREN WITH THE NEPHROTIC SYNDROME. The Lancet 285:7383, pages 463-465.
Crossref
Crossref